Kymera Therapeutics is Biotechnology in United States that focus on Kymera Therapeutics Inc business. Founded in 2015. They cover business area such as Kymera Therapeutics Inc, previously untreatable disease, target protein degradation, disease-cause protein, a focus, un-drug node, validate pathway, conventional therapeutic, drug discovery, an unmatched ability, intractable protein, new treatment option, patient.
2015
( 9 years old in 2024 )
Kymera Therapeutics Inc
-
200 Arsenal Yards Boulevard
Suite 230
Watertown, MA 02472
United States
Private
Kymera Therapeutics Incpreviously untreatable diseasetarget protein degradationdisease-cause proteina focusun-drug nodevalidate pathwayconventional therapeuticdrug discoveryan unmatched abilityintractable proteinnew treatment optionpatient
* We use standard office opening hours in near Kymera Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kymera Therapeutics is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Kymera Therapeutics business is focusing on Kymera Therapeutics Inc.
Kymera Therapeutics headquarter office and corporate office address is located in 200 Arsenal Yards Boulevard Suite 230 Watertown, MA 02472 United States.
Kymera Therapeutics was founded in United States.
In 2024, Kymera Therapeutics is currently focus on Kymera Therapeutics Inc sector.
Above is snippet of Google Trends for "Kymera Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kymera Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
